Skip to main content

New distribution in China

Press release 2010-06-22
New distribution in China                                                       
C-RAD AB with its three fully owned subsidiaries are all active in the field of 
radiation therapy. The company has signed a distribution agreement for the fast 
growing market in China.                                                        
C-RAD has signed an agreement with the Chinese company Beijing KANGLIDA Trading 
Corporation to distribute the C-RAD program on the Chinese market. KANGLIDA has 
a long experience in radiation therapy and excellent relationships with some of 
the most important clinics on the Chinese market. . C-RAD's laser scanner system
Sentinel will for this market be an important system to improve accuracy and    
increase efficiency in patient positioning and motion detection both for use in 
conventional conformal radiation therapy and for the advanced techniques. New   
functionality for respiratory gating will in 2010 be introduced                 

Erik Hedlund, CEO, C-RAD AB:                                                    
"AS a part of the C-RAD focused marketing strategy, we are very pleased to have 
signed a distribution agreement with Beijing KANGLIDA for the Chinese market.   
Relationships with the owners of KANGLIDA are established since middle of the   
China is a demanding market. As a first step the approval process for the C-RAD 
Sentinel system will be started."                                               

For further information:                                                        
Erik Hedlund, CEO C-RAD AB, Telefon 018 - 66 69 31, E-post

About C-RAD AB                                                                  
C-RAD develops new and innovative solutions for the use in advanced radiation   
therapy. The company group of C-RAD offers products and solutions for patient   
positioning, tumor localization and radiation treatment systems. End users are  
radiation therapy clinics worldwide. All product development is conducted in    
three fully owned subsidiaries; C-RAD Positioning AB, C-RAD Imaging AB and C-RAD
Innovation AB. C-RAD Imaging AB is located in Östersund while the other         
companies are located in Uppsala. Numbers of employees are currently 19 people. 
The activities in C-RAD AB originate from research and development at the       
Karolinska Institutet in Solna. Sales of the company's first product, the C-RAD 
SentinelTM, started in 2007. Cooperation agreements have been signed with the   
Swedish company Elekta and the Belgian company IBA. C-RAD is represented by     
distributors specialized in radiation therapy on major markets. C-RAD AB is     
since March 2010 listed at Nasdaq Omx First North Premier.
Close Menu